The Digital Health Dichotomy - Who Gets Funded and Who Doesn’t

In Q1 2026, nearly 60% of digital health investment went to just 12 mega-deals of $100 million or more. This episode breaks down what this funding concentration means for startups and smaller healthcare companies, and provides a practical go-forward strategy for navigating the new reality. Key Topics Covered: The mega-deal phenomenon and what's driving it Why mid-tier and early-stage companies are getting squeezed out Real-world impact on startups and smaller healthcare companies Strategic responses for founders and operators How Life Science Logic helps companies navigate these challenges Resources & Data Sources: Rock Health Q1 2026 Digital Health Funding Report Galen Growth U.S. Digital Health Funding Q1 2026 Analysis Healthcare Dive coverage of H1 2026 funding trends Life Science Logic Intelligence Engine About Life Science Logic: Life Science Logic is a commercial strategy consultancy serving small life science and healthcare companies. We help founders and operators build go-to-market strategies, competitive intelligence, and commercial plans with the clarity and rigor that early-stage companies deserve. Visit https://lifesciencelogic.com/ or reach us at [email protected]. Disclaimer: The information provided in this podcast is for educational and informational purposes only and does not constitute legal, financial, or regulatory advice. Always consult with qualified professionals regarding your specific situation.       Healthcare Logic for Growth  ·  Life Science Logic  ·  [email protected]  ·  © 2026 Life Science Logic